| answer text |
<p>Respiratory disease is a clinical priority within the recently published NHS Long
Term Plan. The Plan has the overarching objective of improving outcomes for people
with respiratory disease, including asthma.</p><p> </p><p>NHS England supports the
national asthma audit programme that provides data on a range of indicators to show
improvements and opportunities for further improvements in asthma outcomes.</p><p>
</p><p>The recently published general practitioner (GP) contract has made improvements
to the Quality and Outcomes framework through the introduction of quality improvement
modules. This replaces the current system of exception reporting with a personalised
care adjustment approach, which will better reflect individual clinical situations
and patients’ wishes. NHS England and GPC England have agreed to an ongoing programme
of indicator review in key priority areas, including asthma in 2019/20. Through the
GP contract and Primary Care Networks, clinical pharmacists will take responsibility
for the care management of patients with chronic diseases and undertake clinical medication
reviews to proactively manage people with complex polypharmacy, and those with multiple
long term conditions, in particular people with chronic obstructive pulmonary disease
and asthma.</p><p> </p><p>National programmes such NHS RightCare are using leading
edge medical evidence and practical support to help local health economies to make
best use of their resources and using tested evidence based processes to make sustainable
improvements to patient care. As part of this programme, a RightCare asthma pathway
will be published in the spring which will outline the optimal pathway for patients,
including the need for follow-up appointments following emergency care.</p>
|
|
